CA2721938C - Chitosan-containing protective composition - Google Patents

Chitosan-containing protective composition Download PDF

Info

Publication number
CA2721938C
CA2721938C CA2721938A CA2721938A CA2721938C CA 2721938 C CA2721938 C CA 2721938C CA 2721938 A CA2721938 A CA 2721938A CA 2721938 A CA2721938 A CA 2721938A CA 2721938 C CA2721938 C CA 2721938C
Authority
CA
Canada
Prior art keywords
polysaccharide
chitosan
composition
derivative
further crosslinker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2721938A
Other languages
English (en)
French (fr)
Other versions
CA2721938A1 (en
Inventor
Edze Jan Tijsma
Maria Nieves Gonzalez
Matthew F. Myntti
Brian J. Vaccaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Publication of CA2721938A1 publication Critical patent/CA2721938A1/en
Application granted granted Critical
Publication of CA2721938C publication Critical patent/CA2721938C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
CA2721938A 2008-04-24 2009-04-23 Chitosan-containing protective composition Active CA2721938C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4759008P 2008-04-24 2008-04-24
US61/047,590 2008-04-24
US10538008P 2008-10-14 2008-10-14
US61/105,380 2008-10-14
PCT/US2009/041592 WO2009132228A1 (en) 2008-04-24 2009-04-23 Chitosan-containing protective composition

Publications (2)

Publication Number Publication Date
CA2721938A1 CA2721938A1 (en) 2009-10-29
CA2721938C true CA2721938C (en) 2016-08-09

Family

ID=40774992

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2721938A Active CA2721938C (en) 2008-04-24 2009-04-23 Chitosan-containing protective composition

Country Status (7)

Country Link
US (1) US8530632B2 (enExample)
EP (1) EP2296637B1 (enExample)
JP (1) JP5757861B2 (enExample)
CN (1) CN102883715B (enExample)
AU (1) AU2009240513B2 (enExample)
CA (1) CA2721938C (enExample)
WO (1) WO2009132228A1 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
KR101610268B1 (ko) 2007-08-28 2016-04-07 애들레이드 리서치 앤드 이노베이션 피티와이 리미티드 외과용 하이드로겔
US20110076332A1 (en) * 2009-08-27 2011-03-31 Xiaojun Yu Dextran-chitosan based in-situ gelling hydrogels for biomedical applications
WO2011060390A2 (en) 2009-11-13 2011-05-19 University Of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
WO2012055596A1 (en) * 2010-10-25 2012-05-03 Albert-Ludwigs-Universität Freiburg Extracellular matrices which can be used as scaffold for living cells
JP5937094B2 (ja) * 2010-10-27 2016-06-22 メドトロニック，インコーポレイテッド 気道に使用する人口かさぶた
US8398611B2 (en) * 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US10500564B2 (en) 2011-03-17 2019-12-10 Perma-Fix Environmental Services, Inc. Preparation of chitosan-based microporous composite material and its applications
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
US10441959B2 (en) 2011-10-28 2019-10-15 Medtronic Xomed, Inc. Multi-orifice spray head
US9486190B2 (en) 2011-10-28 2016-11-08 Medtronic Xomed, Inc. Spray delivery system
US8974436B2 (en) 2011-10-28 2015-03-10 Medtronic Xomed, Inc. Multi-sectioned cannula with multiple lumens
US20130105018A1 (en) 2011-10-28 2013-05-02 Medtronic Xomed, Inc. Turbulence-inducing mixing device
HK1201734A1 (en) * 2011-11-13 2015-09-11 Cresilon, Inc. In-situ cross-linkable polymeric compositions and methods thereof
CA2914610C (en) 2013-03-13 2022-08-02 University Of Maryland Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
KR101664444B1 (ko) * 2013-12-13 2016-10-12 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 생분해성 의료용 접착제 또는 실란트 조성물
EP3139903B1 (en) 2014-05-07 2019-07-03 Croma-Pharma Gesellschaft m.b.H. Aqueous ophthalmic solution and method for treating dry eye syndrome
NZ756435A (en) * 2014-05-29 2022-12-23 Access Closure Inc Chitosan and polyethylene glycol copolymers and methods and devices for using same for sealing a vascular puncture
CA2967391C (en) * 2014-11-19 2023-08-01 Perma-Fix Environmental Services, Inc. Preparation of chitosan-based microporous composite material and its applications
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
US10213521B2 (en) * 2015-06-11 2019-02-26 Medtronic Xomed, Inc. Useful polysaccharide after radiation sterilization
PL3368006T3 (pl) 2015-10-30 2020-06-01 Croma-Pharma Gesellschaft M.B.H. Zastosowanie terapeutyczne sterylnego wodnego roztworu oftalmicznego
CN108348455B (zh) 2015-10-30 2021-04-09 克罗马药品股份有限公司 无菌水性眼用溶液的治疗用途
US9655842B1 (en) * 2015-12-04 2017-05-23 Covidien Lp Injectable non-aqueous compositions and methods of treating vascular disease
US20170157283A1 (en) 2015-12-08 2017-06-08 Medtronic Xomed, Inc. Dissolvable nasal sinus sponge
RU2745077C2 (ru) 2016-06-03 2021-03-19 Конинклейке Филипс Н.В. Введение веществ для ухода за полостью рта
US10576099B2 (en) 2016-10-21 2020-03-03 Covidien Lp Injectable scaffold for treatment of intracranial aneurysms and related technology
CN106421875B (zh) * 2016-11-15 2019-08-27 广州迈普再生医学科技股份有限公司 可降解吸收的止血纤维材料及其制备方法和止血纤维制品
WO2018202783A1 (en) 2017-05-03 2018-11-08 Croma-Pharma Gmbh Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
US10835635B2 (en) 2017-08-04 2020-11-17 Hcs Innovation, Llc Natural polymer based tissue adhesive with healing promoting properties
US11571492B2 (en) * 2017-08-04 2023-02-07 Hcs Innovation, Llc Natural polymer-based tissue adhesive with healing-promoting properties
US12102729B2 (en) 2017-08-04 2024-10-01 Hcs Innovation, Llc Natural polymer-based tissue adhesive with healing-promoting properties
CN121944198A (zh) 2018-01-12 2026-05-01 波士顿科学国际有限公司 实现止血的粉末
KR20200131808A (ko) * 2018-03-14 2020-11-24 마이코워크스, 인크. 진균 재료에서 키틴과 키토산의 탈아세틸화와 가교 결합 및 가변 특성을 위한 복합체
EP3801654B1 (en) * 2018-05-31 2025-12-10 Hcs Innovation Llc Natural polymer-based tissue adhesive with healing-promoting properties
CN114667103A (zh) 2019-11-04 2022-06-24 柯惠有限合伙公司 用于治疗颅内动脉瘤的装置、系统和方法
WO2022198208A1 (en) 2021-03-16 2022-09-22 Covidien Lp Injectable biopolymer compositions and associated systems and methods

Family Cites Families (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3122479A (en) * 1957-11-14 1964-02-25 David F Smith Hemostatic surgical dressings
US3184385A (en) 1961-10-16 1965-05-18 Eastman Kodak Co Dry, vitamin-active product and process for preparing same
US3914214A (en) 1973-08-24 1975-10-21 Us Agriculture Thiolation of polysaccharides
US3989044A (en) 1975-08-11 1976-11-02 Warner-Lambert Company Syringe
EP0112852B1 (en) 1982-06-24 1988-06-08 SMITH, Robert Alan Pharmaceutical gel composition
US4659700A (en) 1984-03-02 1987-04-21 Johnson & Johnson Products, Inc. Chitosan-glycerol-water gel
US4895724A (en) 1985-06-07 1990-01-23 Pfizer Inc. Chitosan compositions for controlled and prolonged release of macromolecules
US4960413A (en) 1985-11-09 1990-10-02 The Shirley Institute Wound dressing
JPS62123112A (ja) 1985-11-22 1987-06-04 Sunstar Inc 軟膏基剤
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
GB9105995D0 (en) 1991-03-21 1991-05-08 Smith & Nephew Wound dressing
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5308546A (en) 1991-12-09 1994-05-03 Glow-Tec Phosphorescent toy gel composition and methods of manufacture
US5550189A (en) 1992-04-17 1996-08-27 Kimberly-Clark Corporation Modified polysaccharides having improved absorbent properties and process for the preparation thereof
US6197346B1 (en) 1992-04-24 2001-03-06 Brown Universtiy Research Foundation Bioadhesive microspheres and their use as drug delivery and imaging systems
US5312324A (en) 1992-09-15 1994-05-17 Walthour Charles D Nasal dressing system
GB2276819B (en) 1993-03-23 1996-12-11 Johnson & Johnson Medical Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5744155A (en) 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
US5531716A (en) 1993-09-29 1996-07-02 Hercules Incorporated Medical devices subject to triggered disintegration
US5622834A (en) 1993-12-01 1997-04-22 Marine Polymer Technologies, Inc. Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture
GB9416884D0 (en) 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
GB9422571D0 (en) 1994-11-09 1995-01-04 Whitehall Lab Ltd Haemorrihoidal compositions and method of use
WO1996031237A2 (en) 1995-04-04 1996-10-10 Wound Healing Of Oklahoma Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
US5679658A (en) 1995-05-08 1997-10-21 Chitogenics, Inc. N,O-carbonxymethylchitosan for prevention of surgical adhesions
US6320029B1 (en) 1996-11-29 2001-11-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
US6458889B1 (en) 1995-12-18 2002-10-01 Cohesion Technologies, Inc. Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
US5985312A (en) 1996-01-26 1999-11-16 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
IL118376A0 (en) 1996-05-22 1996-09-12 Univ Ben Gurion Polysaccharide sponges for cell culture and transplantation
IN192791B (enExample) 1996-06-28 2004-05-22 Johnson & Johnson Medical
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US6545042B2 (en) 1996-11-05 2003-04-08 Gp Medical Acellular biological material chemically treated with genipin
ATA7997A (de) 1997-01-21 1998-03-15 Bernkop Schnuerch Andreas Verfahren zur herstellung von chitosan-ethylendiamintetraacetat konjugaten
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US20050096282A1 (en) 1997-04-21 2005-05-05 Lewin Alfred S. Adeno-associated virus-delivered ribozyme compositions and methods for the treatment of retinal diseases
US20030073663A1 (en) * 1997-06-25 2003-04-17 David M Wiseman Bioabsorbable medical devices from oxidized polysaccharides
CA2212300A1 (en) 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
WO1999027905A1 (en) 1997-12-02 1999-06-10 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Compositions for nasal administration
US6514522B2 (en) 1998-04-08 2003-02-04 Chondros, Inc. Polymer constructs
CA2341732C (en) 1998-08-26 2008-08-19 Teijin Limited Powder composition for nasal administration
AT406054B (de) 1998-11-04 2000-02-25 Andreas Bernkop-Schnuerch Verfahren zur verbesserung der mucoadhäsion von polymeren sowie deren herstellung und verwendung
JP4606586B2 (ja) 1998-11-10 2011-01-05 株式会社ネーテック 機能性キトサン誘導体
EP1137373A4 (en) 1998-12-04 2004-05-19 Chandrashekhar P Pathak BIOCOMPATIBLE, CROSSLINKED POLYMERS
US6645947B1 (en) 1999-05-20 2003-11-11 Chitogenics, Inc. Adhesive N, O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
AU1249001A (en) 1999-06-11 2001-01-31 Nektar Therapeutics Al, Corporation Hydrogels derived from chitosan and poly(ethylene glycol) or related polymers
EP1228771A4 (en) 1999-11-09 2003-01-29 Denki Kagaku Kogyo Kk USE OF SOLUBLE CELLULOSE DERIVATIVES MADE DIFFICULTLY SOLUBLE IN WATER AND METHOD OF PREPARING SUCH DERIVATIVES
AU4741001A (en) 2000-03-14 2001-09-24 Alcon Universal Ltd Viscoelastics for use in middle ear surgery
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
US6991652B2 (en) 2000-06-13 2006-01-31 Burg Karen J L Tissue engineering composite
DE10035799A1 (de) * 2000-07-22 2002-01-31 Kalle Nalo Gmbh & Co Kg Nach dem Aminoxidverfahren hergestellte Nahrungsmittelhüllen auf Cellulosebasis
GB0018527D0 (en) 2000-07-27 2000-09-13 Photocure Asa Composition
US6417347B1 (en) 2000-08-24 2002-07-09 Scimed Life Systems, Inc. High yield S-nitrosylation process
IT1317358B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
US6989373B2 (en) 2000-11-15 2006-01-24 Bio Syntech Canada Inc. Method for restoring a fat-pad
JP2005513081A (ja) 2000-12-13 2005-05-12 パーデュー・リサーチ・ファウンデイション 溶媒交換による薬剤のマイクロカプセル化
AU2002249046A1 (en) 2001-04-23 2002-11-05 Nucryst Pharmaceuticals Corp. Lubricious coatings for substrates
JP3611534B2 (ja) * 2001-04-26 2005-01-19 株式会社エス・エヌ・シー 高分子包接性化合物からなる有害物質除去のための繊維およびその製造方法ならびに使用
EP1392182A1 (en) 2001-05-04 2004-03-03 Concentric Medical Hydrogel vaso-occlusive device
US20060004314A1 (en) 2001-06-14 2006-01-05 Hemcon, Inc. Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan
ATA13842001A (de) 2001-08-31 2002-10-15 Mucobiomer Biotechnologische F Chitosan-thio-alkyl-amidin konjugate und deren kosmetische sowie pharmazeutische verwendung
DE10152407A1 (de) * 2001-10-24 2003-05-08 Aesculap Ag & Co Kg Zusammensetzung aus mindestens zwei biokompatiblen chemisch vernetzbaren Komponenten
ES2357889T3 (es) 2001-11-15 2011-05-03 Piramal Healthcare (Canada) Limited Composición y método para reticular o modificar homogéneamente quitosano en condiciones neutras.
US20030187381A1 (en) 2001-12-28 2003-10-02 Genzyme Corporation Bioresorbable foam packing device and use thereof
US6664301B1 (en) 2002-02-20 2003-12-16 Robert D. Kross Method for using glycol additives to texturally modify natural gum hydrogels
GB2386900B (en) 2002-03-25 2006-11-01 Johnson & Johnson Medical Ltd Use in wound dressings of chemically modified polysaccharides
CA2484453A1 (en) * 2002-04-23 2003-11-06 Netech Inc. Medicinal compositions containing photocrosslinkable chitosan derivative
AU2003299509A1 (en) 2002-06-21 2004-05-13 University Of Utah Research Foundation Crosslinked compounds and methods of making and using thereof
US20050019404A1 (en) 2003-06-30 2005-01-27 Hsing-Wen Sung Drug-eluting biodegradable stent
US7070582B2 (en) 2002-08-09 2006-07-04 Boston Scientific Scimed, Inc. Injection devices that provide reduced outflow of therapeutic agents and methods of delivering therapeutic agents
GB2393120A (en) * 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US8673333B2 (en) 2002-09-25 2014-03-18 The Johns Hopkins University Cross-linked polymer matrices, and methods of making and using same
US7862831B2 (en) 2002-10-09 2011-01-04 Synthasome, Inc. Method and material for enhanced tissue-biomaterial integration
CA2501820C (en) 2002-10-08 2009-12-15 Ricom Corporation Chitosan-containing polysaccharide, method for preparing the same and use thereof
US20050069572A1 (en) 2002-10-09 2005-03-31 Jennifer Elisseeff Multi-layered polymerizing hydrogels for tissue regeneration
US7229966B2 (en) 2002-12-17 2007-06-12 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
TWI251596B (en) 2002-12-31 2006-03-21 Ind Tech Res Inst Method for producing a double-crosslinked hyaluronate material
DE10318802A1 (de) 2003-04-17 2004-11-04 Aesculap Ag & Co. Kg Selbsthaftendes resorbierbares Hämostyptikum
US7384557B2 (en) * 2003-07-14 2008-06-10 Applied Ambient Extraction Process Consultants, Llc Method and apparatus for removing solute from a solid solute-bearing product
US7901707B2 (en) 2004-03-15 2011-03-08 Christine Allen Biodegradable biocompatible implant and method of manufacturing same
US7740883B2 (en) * 2004-03-28 2010-06-22 University Of Debrecen Nanoparticles from chitosan
JP2008506750A (ja) 2004-07-22 2008-03-06 ティオマトリックス・フォルシュンクス・ウント・べラートゥンクス・ゲーエムベーハー チオール基を含む化合物の排出ポンプ抑制剤としての使用
US7282194B2 (en) 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
US8703659B2 (en) * 2005-01-24 2014-04-22 Halliburton Energy Services, Inc. Sealant composition comprising a gel system and a reduced amount of cement for a permeable zone downhole
US7834065B2 (en) 2005-01-31 2010-11-16 Bmg Incorporated Medical-use two part reactive adhesive and medical-use resin having self-degradation property
WO2006092799A1 (en) 2005-03-02 2006-09-08 Polyrizon Ltd. Method for removal of toxins from mucosal membranes
TW200719884A (en) 2005-03-10 2007-06-01 3M Innovative Properties Co Methods of treating ear infections
AU2006244873A1 (en) 2005-05-13 2006-11-16 Netech Inc. Medical composition for promotion of skin regeneration
DE102005030011A1 (de) 2005-06-17 2006-12-21 Aesculap Ag & Co. Kg Verfahren zur Herstellung von sterilen Polysaccharidlösungen
US20070031467A1 (en) 2005-08-04 2007-02-08 Abrahams John M Composition and method for vascular embolization
FR2889449B1 (fr) 2005-08-05 2011-06-10 Khorionyx Preparations implantables
US20070087059A1 (en) 2005-10-17 2007-04-19 Frank Everaerts Bioactive delivery matrix compositions and methods
US20070110788A1 (en) 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
CA2637616A1 (en) 2006-01-19 2007-07-26 Osteotech, Inc. Injectable and moldable bone substitute materials
FR2897775B1 (fr) 2006-02-24 2013-05-03 Elisabeth Laugier Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations
US20080069857A1 (en) * 2006-04-12 2008-03-20 Yoon Yeo Compositions And Methods For Inhibiting Adhesions
US20070243130A1 (en) 2006-04-18 2007-10-18 Weiliam Chen Biopolymer system for tissue sealing
US20090010982A1 (en) 2006-04-18 2009-01-08 Endomedix, Inc. Biocompatible adherent sheet for tissue sealing
US20080075657A1 (en) * 2006-04-18 2008-03-27 Abrahams John M Biopolymer system for tissue sealing
US7854923B2 (en) 2006-04-18 2010-12-21 Endomedix, Inc. Biopolymer system for tissue sealing
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
CN100348272C (zh) 2006-06-23 2007-11-14 华南理工大学 可溶性纤维素止血海绵的制备方法
US8313762B2 (en) 2006-07-05 2012-11-20 Medtronic Xomed, Inc. Flexible bioresorbable hemostatic packing and stent
WO2008008857A2 (en) 2006-07-11 2008-01-17 University Of Utah Research Foundation Thiolated macromolecules and methods of making and using thereof
WO2008067655A1 (en) 2006-12-05 2008-06-12 Q6 Biomaterials Inc. Biocompatible hydrogel-based scaffolds
JP2008247975A (ja) 2007-03-29 2008-10-16 Daicel Chem Ind Ltd 架橋ゲルおよびそれを用いた吸収体
JP2008285611A (ja) 2007-05-18 2008-11-27 Daicel Chem Ind Ltd 架橋ゲルの製造方法及びその架橋ゲル
JP2009040697A (ja) 2007-08-07 2009-02-26 Asuka Corporation:Kk 化粧料組成物
US20090062233A1 (en) 2007-08-09 2009-03-05 Xin Ji Modified starch material of biocompatible hemostasis
KR101610268B1 (ko) 2007-08-28 2016-04-07 애들레이드 리서치 앤드 이노베이션 피티와이 리미티드 외과용 하이드로겔

Also Published As

Publication number Publication date
WO2009132228A1 (en) 2009-10-29
CA2721938A1 (en) 2009-10-29
EP2296637A1 (en) 2011-03-23
JP2011518839A (ja) 2011-06-30
JP5757861B2 (ja) 2015-08-05
US20090291912A1 (en) 2009-11-26
EP2296637B1 (en) 2014-04-02
CN102883715A (zh) 2013-01-16
AU2009240513B2 (en) 2015-03-26
US8530632B2 (en) 2013-09-10
CN102883715B (zh) 2014-11-12
AU2009240513A1 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
AU2009240513B2 (en) Chitosan-containing protective composition
AU2009240512B2 (en) Protective gel based on chitosan and oxidized polysaccharide
AU2009240510B2 (en) Rehydratable polysaccharide particles and sponge
AU2009240509B2 (en) Rehydratable thiolated polysaccharide particles and sponge
AU2011319947B2 (en) Artificial scab for use in an airway

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140310

H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20251023

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20251106

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251107